Order of the President of the Court of First Instance of 31 October 2000 in Case T-83/00 R-I: Hänseler GmbH v Commission of the European Communities (Proceedings for interim relief — Withdrawal of marketing authorisation for medicinal products for human use containing norpseudoephdrine — Directive 75/319/EEC — Urgency — Need to balance interests)
Date: 2001-04-07
Institutions: Court of First Instance
Subjects: European Commission, Germany, action for annulment (EU), market approval, medicinal product, pharmaceutical industry

7.4.2001

EN

Official Journal of the European Communities

C 108/21

ORDER OF THE PRESIDENT OF THE COURT OF FIRST
INSTANCE

of 31 October 2000

in Case T-83/00 R-I: Hänseler GmbH v Commission of the
European Communities

(Proceedings for interim relief — Withdrawal of marketing
authorisation for medicinal products for human use contain-
ing norpseudoephdrine — Directive 75/319/EEC — Urgency
— Need to balance interests)

(2001/C 108/38)

(Language of the case: German)

In Case T-83/00 R-I: Hänseler GmbH, established in Konstanz
(Germany), represented by B. Sträter, Rechtsanwalt, Bonn,
Germany, with an address for service in Luxembourg at the
Chambers of Bonn and Schmidt, 7 Val Sainte-Croix, against
the Commission of
the European Communities (Agents:
H. Støvlbæk and B. Wägenbaur) — application for the
suspension of application of the decision of the Commission
of 9 March 2000 concerning the withdrawal of authorisations
for placing on the market medicinal products for human
consumption containing in particular norpseudoephedrine
(C(2000) 608) — the President of the Court of First Instance
made an order on 31 October 2000, the operative part of
which is as follows:

1.

the decision of

The application to the applicants of
the
Commission of 9 March 2000 concerning the withdrawal of
authorisations for placing on the market medicinal products for
human consumption containing Clobenzorex, Fenbutrazat,
Fenproporex, Mazindol, Mefenorex, Norpseudoephedrine,
Phenmetrazine,
Propylhexedrine
(C(2000) 608) is suspended.

Phendimetrazine

and

2.

Costs are reserved.

ORDER OF THE PRESIDENT OF THE COURT OF FIRST
INSTANCE

of 31 October 2000

in Case T-83/00 R-II: Schuck GmbH v Commission of the
European Communities

(Proceedings for interim relief — Withdrawal of marketing
authorisation for medicinal products for human use contain-
ing norpseudoephdrine — Directive 75/319/EEC — Urgency
— Need to balance interests)

(2001/C 108/39)

(Language of the case: German)

In Case T-83/00 R-II: Schuck GmbH, established in Schwaig
(Germany), represented by B. Sträter, Rechtsanwalt, Bonn,

Germany, with an address for service in Luxembourg at the
Chambers of Bonn and Schmidt, 7 Val Sainte-Croix, against
the European Communities (Agents:
the Commission of
H. Støvlbæk and B. Wägenbaur) — application for the
suspension of application of the decision of the Commission
of 9 March 2000 concerning the withdrawal of authorisations
for placing on the market medicinal products for human
consumption containing in particular norpseudoephedrine
(C(2000) 608) — the President of the Court of First Instance
made an order on 31 October 2000, the operative part of
which is as follows:

1.

the decision of

The application to the applicants of
the
Commission of 9 March 2000 concerning the withdrawal of
authorisations for placing on the market medicinal products for
human consumption containing Clobenzorex, Fenbutrazat,
Fenproporex, Mazindol, Mefenorex, Norpseudoephedrine,
Phenmetrazine,
Propylhexedrine
(C(2000) 608) is suspended.

Phendimetrazine

and

2.

Costs are reserved.

ORDER OF THE PRESIDENT OF THE COURT OF FIRST
INSTANCE

of 31 October 2000

in Case T-132/00 R: Gerot Pharmazeutika GmbH v the
Commission of European Communities

(Proceedings for interim relief — Withdrawal of marketing
authorisation for medicinal products for human use contain-
ing phentermine — Directive 75/319/EEC — Urgency —
Need to balance interests)

(2001/C 108/40)

(Language of the case: German)

In Case T-132/00 R: Gerot Pharmazeutika GmbH, established
in Vienna, represented by B. Sträter, Rechtsanwalt, Bonn,
Germany, with an address for service in Luxembourg at the
Chambers of Bonn and Schmidt, 7 Val Sainte-Croix, against
the Commission of
the European Communities (Agents:
H. Støvlbæk and B. Wägenbaur) — application for the
suspension of application of the decision of the Commission
of 9 March 2000 concerning the withdrawal of authorisations
for placing on the market medicinal products for human
consumption containing phentermine (C(2000) 452) — the
President of the Court of First Instance made an order on
31 October 2000, the operative part of which is as follows:

1.

The application to the applicants of
the
Commission of 9 March 2000 concerning the withdrawal of
authorisations for placing on the market medicinal products
for human consumption containing the following substance:
phentermine (C(2000) 452) is suspended.

the decision of

2.

Costs are reserved.